Related references
Note: Only part of the references are listed.Presenting symptoms of glioma in adults
J. P. Posti et al.
ACTA NEUROLOGICA SCANDINAVICA (2015)
Epidemiologic and Molecular Prognostic Review of Glioblastoma
Jigisha P. Thakkar et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy
Michael Weller et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Incidence and relative survival of anaplastic astrocytomas
Nicolas R. Smoll et al.
NEURO-ONCOLOGY (2014)
Molecular pathologic diagnosis of epidermal growth factor receptor
Cecile L. Maire et al.
NEURO-ONCOLOGY (2014)
Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2014)
Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes
Marianne Labussiere et al.
NEUROLOGY (2014)
Epidermal growth factor receptor targeting in cancer: A review of trends and strategies
Chetan Yewale et al.
BIOMATERIALS (2013)
Screening for EGFR Amplifications with a Novel Method and Their Significance for the Outcome of Glioblastoma Patients
Michal Bienkowski et al.
PLOS ONE (2013)
IDH1/IDH2 Mutations Define the Prognosis and Molecular Profiles of Patients with Gliomas: A Meta-Analysis
Peng Zou et al.
PLOS ONE (2013)
Paradoxical Relationship Between the Degree of EGFR Amplification and Outcome in Glioblastomas
Jonathan Hobbs et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Anaplastic Glioma
Nina A. Paleologos et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2012)
Glioblastoma survival in the United States before and during the temozolomide era
Derek R. Johnson et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme
R. Helseth et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas
Sasha Gulati et al.
DIAGNOSTIC PATHOLOGY (2010)
Age-dependent prognostic effects of EGFR/p53 alterations in glioblastoma: study on a prospective cohort of 140 uniformly treated adult patients
M. R. Srividya et al.
JOURNAL OF CLINICAL PATHOLOGY (2010)
Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies
Philip C. De Witt Hamer
NEURO-ONCOLOGY (2010)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
ANNALS OF INTERNAL MEDICINE (2009)
Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients
Joerg Felsberg et al.
CLINICAL CANCER RESEARCH (2009)
Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951
Mathilde C. M. Kouwenhoven et al.
NEURO-ONCOLOGY (2009)
Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas
Ahmed Idbaih et al.
NEURO-ONCOLOGY (2008)
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma
Christopher E. Pelloski et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prognostic factors for anaplastic astrocytomas
Alessia Compostella et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Prognostic impact of molecular markers in a series of 220 primary glioblastomas
C Houillier et al.
CANCER (2006)
Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme - Prognostic significance and relationship to other prognostic factors
LJ Layfield et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2006)
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
IK Mellinghoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Genetic analyses for predictors of radiation response in glioblastoma
HA Shih et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme
AL Quan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
The natural history of EGFR and EGFRvIII in glioblastoma patients
AB Heimberger et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib
DA Haas-Kogan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients
AB Heimberger et al.
CLINICAL CANCER RESEARCH (2005)
Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance
KD Aldape et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Age-dependent prognostic effects of genetic alterations in glioblastoma
TT Batchelor et al.
CLINICAL CANCER RESEARCH (2004)
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme
JS Smith et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Empirical assessment of effect of publication bias on meta-analyses
AJ Sutton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Share Paper
